USA Patient Registry Software Market Outlook to 2028, Featuring IQVIA, Optum (UnitedHealth Group), Phytel, Dacima Software, FIGmd, Syapse and Pharos Innovations – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “USA Patient Registry Software Market Outlook to 2028” report has been added to ResearchAndMarkets.com’s offering.


The United States has one of the largest Patient registry software markets in the world. In the United States, building digital infrastructure for healthcare and electronic record health adoption started earlier. The patient registry market in the US involves the collection, management & analysis of data related to patients with specific medical conditions & diseases. These registries play a crucial role in medical research, healthcare quality improvement, monitoring treatment outcomes & assessing the effectiveness of interventions. They provide valuable insights for healthcare providers, researchers, policy makers & pharmaceutical companies.

Patient registries contribute to evidence-based medicine by providing real-world data that complements single trial findings. This is particularly important for conditions where clinical trials may not be feasible or representative. With the increasing prevalence of chronic diseases in the United States, patient registries help medical officials track disease progression, treatment outcomes & long-term management strategies. Pharmaceutical companies & researchers can leverage patient registries to identify best practices, areas for improvement & variations in care delivery. The digitization of health records & adoption of electronic health records (EHRs) have streamline data collection & management for patient registries. Few major players operating in the market include IQVIA, Optum, Dacima Software, etc. to name a few.

USA Patient Registry Software market consists of both consolidated & fragmented players. There are numerous companies which have been offering various solutions for different aspects of healthcare including patient registries. Some of the leading players include IQVIA, FIGmd, Dacima Software, etc. The fragmented nature is due to the diverse needs of healthcare providers, organizations & research institutions, leading to a wide array of software options catered to different specialties, sizes of organizations & functionalities.

USA Patient Registry Software Market Analysis

United States, within the Northern region is expected to dominate the market. In the United States, digital infrastructure development for healthcare & infrastructure is on the rise. The federal government has been encouraging the use of its healthcare data through various policies & initiatives for new researches.

The National Pancreas Foundation (NPF) launched the pancreatic disease patient registry with SeqesterOS. The patient centric registry gave patients & their caregivers the ability to create their longitudinal patient records with data from any EHR, genomic DNA test and wearable/remote monitoring device.

The Rare Diseases Clinical Research Network (RDCRN) launched a contact registry to connect rare disease research. The registry will collect & maintain information of people who want to receive information of people who want to receive information about rare disease research.

Many prominent federal & state agencies such as National Institutes of Health (NIH), Centers for Medicare & Medicaid Services (CMS), Food & Drug Administration (FDA), Centers for Disease Control & Prevention (CDC). They’re concentrating their efforts on creation of patient registries with goal of determining long-term outcome of devices, agents, groups of drugs, procedures.

Key Trends by Market Segment:

By Type of Registry: Disease Registry has been the most dominant segment in 2022. This segment is highly useful to gather, organize & analyse data related to specific diseases or medical conditions. The country has a high prevalence for chronic diseases like diabetes, cancer and respiratory disorders. Disease registries are particularly effective in managing & understanding chronic conditions which makes it a critical tool for medical researchers & clinicians

By Application: Government & third-party organizations have been the dominant segment in 2022. Since government agencies have substantial funding & resources, enabling them to invest in the development & maintenance of patient registry software. They can allocate budgets for software development, system updates & ongoing support

By Geography: The Eastern region of USA is known for its highly developed healthcare infrastructure, including major cities like New York, Boston & Chicago. In 2022, Eastern region have dominated the patient registry market because of the prominent medical research & clinical institutions which are present in the state

The East Coast is home to some of the most renowned medical institutions and research centers in the country. These institutions prioritize patient registry software to track and analyze data for research, clinical trials, and improving patient outcomes

Many technology companies and startups are concentrated on the East Coast, particularly in the Boston-Washington D.C. corridor. This could lead to increased innovation and development of patient registry software solutions in the region, potentially boosting its dominance

The East Coast dominates, due to its urban centers and established healthcare systems, might have more stringent regulations and compliance requirements. This will drive the need for robust patient registry solutions to ensure data security, privacy, and compliance with healthcare regulations

The presence of numerous universities, medical schools, and research institutions on the East Coast has encouraged collaborations and partnerships in healthcare research. Patient registry software could facilitate data sharing and analysis among these entities, leading to increased adoption

Competitive Landscape:

The patient registry software market in the USA is a part of the broader healthcare information technology sector. Patient registry software helps healthcare providers, researchers & organizations collect, manage & analyse patient data for various purposes, such as research, disease management, quality improvement and clinical trials. Key players in the USA patient registry software market includes IQVIA, Dacima Software, OpenClinica, FIGmd, Dendrite Clinical Systems and various universities conducting medical clinical studies. These registries often focus on special diseases like cancer, rare diseases. Government agencies & healthcare organizations may collaborate to create patient registries for public health surveillance & research. These initiatives can provide valuable insights into population health trends & outcomes.

Future Outlook:

USA Patient Registry Software is expected to show increasing and is expected to grow at a CAGR of ~11% from 2022 to 2028 because of the Government initiatives & technological advancements leading to higher demand for patient registry software. As technology & data science continue to evolve, the patient registry software market is likely to incorporate more advanced analytics techniques. This will lead to more sophisticated insights into patient populations, treatment outcomes & disease patterns.

The healthcare industry is increasingly focused on data interoperability & sharing among different healthcare systems & providers. Patient registry software needs to adapt to these trends by offering better integration with electronic health records (EHR) & other healthcare IT systems.

Pharmaceutical companies & regulatory agencies are showing growing interest in using real-world evidence (RWE) from patient registries to inform drug development & regulatory decisions. The integration of wearable devices & Internet of Things (IoT) technologies could provide real time data to patient registries. This data could offer a more comprehensive view of patients’ health statuses & treatment responses.

Company Profiles – (Top Players)

IQVIA

Optum (UnitedHealth Group)

Phytel

Dacima Software

FIGmd

Syapse

Pharos Innovations

For more information about this report visit https://www.researchandmarkets.com/r/70ltcj

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900